Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Kenvue

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the White House. Late last month, President Donald Trump stated on Truth Social that pregnant women shouldn't use Tylenol unless absolutely necessary. With…

Benzinga

'This team is guided by science': Kenvue chief hits back at Trump and RFK Jr.'s Tylenol autism claims in memo to 20,000 employees

Promotion of unproven claims from President Trump and RFK Jr. linking acetaminophen (Tylenol) to autism have significantly impacted Kenvue’s business.

Fortune

White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend…'

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

RFK Jr. wanted to blame Tylenol for autism after meeting with drugmaker CEO

Trump was eager to single out drug manufacturer despite no new evidence to support administration’s unproven claims

The Independent UK

As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stock’s Here?

Kenvue stock is trailing the broader markets by a wide margin in 2025 due to regulatory concerns over its flagship Tylenol product.

Barchart

Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning

Kenvue Inc. (NYSE:KVUE) saw its stock rise by 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns stirred by President Trump's controversial comments about acetaminophen potentially being linked to autism.

Benzinga

Jon Stewart Roasts Trump Over 'Acetaminophen' Pronunciation: 'We Would Like A Second Opinion'

Comedian Jon Stewart mocked President Donald Trump on The Daily Show after the president struggled to pronounce "acetaminophen" while warning pregnant women about a possible link to autism.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Tylenol maker prepares for glut of lawsuits after Trump’s baseless warnings

‘Don’t take Tylenol,’ President Donald Trump repeatedly warned on Monday

The Independent UK

Fact-checking Trump's paracetamol and autism announcement

President Donald Trump made several claims during his conference to announce a ‘link’ between Tylenol and autism - but how much is true?

Evening Standard

What's Going On With Kenvue Stock Tuesday?

Kenvue Inc. (NYSE:KVUE) shares are trading higher Tuesday despite President Donald Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with increase risk of autism.

Benzinga

Tylenol maker rebounds a day after Trump's unfounded claims about its safety

Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism

The Independent UK

What Is the 'Tylenol Murders' and Why Does the Famous Analgesic Keep Getting Linked to Controversies?

More than 40 years after the unexpected deaths of seven people due to tainted medicine, Tylenol became the centre of attention again for a different reason.

International Business Times UK

Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism

CNBC’s Jim Cramer warned Tuesday that President Donald Trump is creating a “nightmare of potential litigation” for consumer health giant Kenvue Inc. (NYSE:KVUE), sending the company's stock tumbling.

Benzinga

Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54. The SP 500 added 0.4% to finish at 6,693.75, while the Nasdaq climbed 0.7% to 22,788.98.These are the top stocks that gained the attention of retail traders and investors through the day: Nvidia…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Trump urges pregnant women to limit taking Tylenol

He simultaneously touted a little-known drug called leucovorin as a way to decrease the symptoms of autism.

Fortune

Tylenol-maker Kenvue's stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials

Kenvue rebuked claims of a connection between autism and acetaminophen and said it is “deeply concerned with the health risk this poses for expecting mothers.”

Benzinga

Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off?

Shares of Kenvue Inc (NASDAQ:KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products.

Axios

Tylenol maker Kenvue blasts Trump administration's autism claim

The over-the-counter drug is a critical product for Kenvue.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Jim Cramer's Warning On This Oil Stock: 'You Don't Want To Be In It'

On CNBC's “Mad Money Lightning Round,” Jim Cramer said The Western Union Company (NYSE:WU) has got no growth.

Benzinga

Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report

Kenvue Inc. (NYSE:KVUE) interim CEO Kirk Perry met privately this week with Health Secretary Robert F. Kennedy Jr. to argue that there is no proven link between the popular pain reliever Tylenol and autism.

Barchart

Is Kenvue Stock Underperforming the Dow?

Despite Kenvue’s recent underperformance relative to the Dow, analysts remain moderately optimistic about the stock’s prospects.

Fortune

Tylenol maker's stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a 'major overreaction'

Canaccord Genuity went on social media to gauge the reaction. Even the MAHA crowd was mixed on this one.

Fortune

RFK Jr.'s planned report linking Tylenol to autism crashes shares of parent company Kenvue

RFK Jr. is preparing a report that will allegedly claim a link between prenatal Tylenol (acetaminophen) use and autism.

The Independent UK

Health Secretary RFK Jr to link Autism and Tylenol use in pregnancy sending company’s stock price spiraling

A report from the Department of Health and Human Services, touted by Trump and Kennedy in April, is expected to be published this month

International Business Times UK

Tylenol In The Firing Line: RFK Jr. Autism Study Triggers Outrage, Market Rout And Big Pharma Panic

RFK Jr.'s autism study linking Tylenol in pregnancy to disorders sparks Big Pharma panic, political backlash and a fierce debate over corporate power.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.